The Fibroblast Growth Factor signaling pathway

Ornitz, David M., Itoh, Nobuyuki·2015·WIREs Developmental Biology
DOI 10.1002/wdev.176

Cited by (1,019)

Items 1,001–1,019 of 1,019

  1. Modulation of FGF pathway signaling and vascular differentiation using designed oligomeric assemblies
    N. Edman, Rachel L. Redler, A. Phal, Thomas Schlichthaerle, S. Srivatsan, Ali Etemadi, Seong J. An, Andrew Favor, D. Ehnes, Zhe Li et al. · 2023 · bioRxiv
  2. [Fibroblast growth factor (FGF) endocrines and pulmonary fibrogenesis].
    M. Ghanem, A. Mailleux, B. Crestani · 2023 · Revue des maladies respiratoires
  3. La voie de signalisation FGFR3
    V. Porquet-Bordes · 2023 · Perfectionnement en Pédiatrie
  4. Activating mutations in FGFR3 are associated with clonal expansion events and high de novo rates in the male germline
    S. Moura, Ingrid Hartl, Atena Yasari, Veronika Brumovská, Yasmin Striedner, M. Bishara, T. Mair, T. Ebner, G. Schütz, E. Sevcsik et al. · 2022 · bioRxiv
  5. Kub3 Deficiency Causes Aberrant Late Embryonic Lung Development in Mice by the FGF Signaling Pathway
    Guang-Ying Yang, S. Lu, Jia Jiang, Jun Weng, Xiaomei Zeng · 2022 · International Journal of Molecular Sciences
  6. From the Gut to the Lung: Evidence of Antifibrotic Activity of Endocrine Fibroblast Growth Factor 19
    R. Guzy, S. Bollenbecker, S. Krick · 2022 · American Journal of Respiratory Cell and Molecular Biology
  7. Clinical and radiologic evaluation of a Turkish family with hypochondroplasia and a rare FGFR3 variant
    Sadiye Ekinci, Yasemin Ülger, Mustafa Oğuz Acar, A. Ceran, Z. Aycan, Ö. S. Fitoz, Hatice Ilgın Ruhi · 2022 · Journal of Pediatric Endocrinology & Metabolism (JPEM)
  8. Refining triple negative breast cancer targeted therapy: special focus on tyrosine kinase receptors
    Asmaa Ramzy Yosseff, H. Nafea, Omar Mohammed El-Tahtawy, L. Rashan, M. el-Shazly, R. A. Youness · 2022 · Scaffold Press Books
  9. Paracrine Fibroblast Growth Factor-Based Therapy: An Unexpected Panacea for Metabolic-Dysfunction-Associated Fatty Liver Disease (MAFLD)
    Tong-Tong Pan, Ting Li, Lumin Shi, Li-Huang Su, Yong-Ping Chen · 2022 · Infectious Microbes & Diseases
  10. Quinacrine binds to the kinase domain of FGFR1 and inhibits its activity
    Makhan Kumar, Angshuman Sarkar · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  11. The Role of Selected Signaling Pathways and Transcription Factors in Chondrogenesis
    J. Ayariga · 2021 · Preprints.org
  12. Temperature-responsive structural reversibility of FGF21 and structure-based design of its variant with enhanced potency
    Y. Jung, Kyeong Won Lee, J. Cho, D. Bae, B. Jeong, Yeon-Ju Jung, Young-Jun An, Kyungchan Kim, G. Lee, Lin-Woo Kang et al. · 2021 · bioRxiv
  13. From Fragment to Lead: A Structure-Guided Approach Towards a Selective FGFR2 Inhibitor
    Lewis D Turner, C. Trinh, Ryan A Hubball, Kyle M Orritt, Chi-Chuan Lin, J. Burns, M. Knowles, C. Fishwick · 2021
  14. Fibroblastic Growth Factor as a Diagnostic and Prognostic Marker in Odontogenic Cysts and Tumors: A Systematic Review
    G. N. Rao, Adlin Saroja Rosaian, Gowthami Jawahar, P. Raj, J. Rachel, P. Emmanuel · 2021 · Journal of Pharmacy and Bioallied Sciences
  15. Therapy that Targets Growth Factor Receptors: Novel Approach for Liver Cirrhosis Treatment
    H. Kuznietsova, Olexandr Ogloblya · 2021 · IntechOpen eBooks
  16. The canonical FGF-FGFR signaling system at the molecular level
    P. Szybowska, E. Haugsten, A. Wiedlocha · 2021 · Postępy Higieny i Medycyny Doświadczalnej
  17. Perikardial Sıvıdan İzole Edilen Hücrelere Fibroblast Büyüme Faktörü (FGF-2) Etkisinin Analizi
    Dilek Sonmezer, Güler Toprak, Ayhan Düzler, F. Latifoğlu · 2020
  18. Fibroblast Growth Factors
    P. Chiodelli, M. Presta · 2020 · Encyclopedia of Molecular Pharmacology
  19. Deneysel Otizm Spektrum Bozukluğu Modeli Oluşturulan Sıçanlarda Likopenin Beyin IL–6, IL–10, FGF–2 ve NGF Düzeyleri Üzerine Etkisi
    F. Erten, H. Gençoğlu, S. Kazim · 2020 · Dicle Üniversitesi Veteriner Fakültesi Dergisi